ArticleCancer research2022

A Probody T Cell-Engaging Bispecific Antibody Targeting EGFR and CD3 Inhibits Colon Cancer Growth with Limited Toxicity.

Leila M Boustany et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.